Estados Unidos · Mercados regionales · Decrypt

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

Publicado por Decrypt · Estados Unidos hace 2 h

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to…

Leer el artículo completo en Decrypt Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (decrypt.co)

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

También te puede interesar

SpaceX says its capex could double this quarter as AI spending grows

Riots leave France divided and shadowed by debt as Macron enters his final run

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

Compartir

También te puede interesar

SpaceX says its capex could double this quarter as AI spending grows

Riots leave France divided and shadowed by debt as Macron enters his final run